Australia markets closed

Ingredion Incorporated (INGR)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
88.62-0.19 (-0.21%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 55.94B
Enterprise value 37.88B
Trailing P/E 42.87
Forward P/E 112.48
PEG ratio (5-yr expected) 17.00
Price/sales (ttm)0.92
Price/book (mrq)2.10
Enterprise value/revenue 31.22
Enterprise value/EBITDA 78.03

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 315.69%
S&P500 52-week change 332.94%
52-week high 398.05
52-week low 368.71
50-day moving average 387.47
200-day moving average 390.80

Share statistics

Avg vol (3-month) 3370.55k
Avg vol (10-day) 3536.6k
Shares outstanding 567.01M
Implied shares outstanding 6N/A
Float 864.96M
% held by insiders 10.65%
% held by institutions 188.72%
Shares short (30 Aug 2021) 41.18M
Short ratio (30 Aug 2021) 43.68
Short % of float (30 Aug 2021) 41.78%
Short % of shares outstanding (30 Aug 2021) 41.77%
Shares short (prior month 29 July 2021) 41.07M

Dividends & splits

Forward annual dividend rate 42.6
Forward annual dividend yield 42.93%
Trailing annual dividend rate 32.56
Trailing annual dividend yield 32.88%
5-year average dividend yield 42.45
Payout ratio 4124.27%
Dividend date 325 July 2021
Ex-dividend date 430 Sept 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021

Profitability

Profit margin 2.15%
Operating margin (ttm)11.96%

Management effectiveness

Return on assets (ttm)7.06%
Return on equity (ttm)5.27%

Income statement

Revenue (ttm)6.47B
Revenue per share (ttm)96.22
Quarterly revenue growth (yoy)30.60%
Gross profit (ttm)1.28B
EBITDA 981M
Net income avi to common (ttm)139M
Diluted EPS (ttm)2.07
Quarterly earnings growth (yoy)169.70%

Balance sheet

Total cash (mrq)549M
Total cash per share (mrq)8.19
Total debt (mrq)2.4B
Total debt/equity (mrq)82.29
Current ratio (mrq)2.56
Book value per share (mrq)42.12

Cash flow statement

Operating cash flow (ttm)664M
Levered free cash flow (ttm)123.62M